China's State General Administration of Sport has officially released the "15th Five-Year Plan for Building a Leading Sports Nation," following approval from the State Council.
Authorities have provided clarifications on the plan's formulation and implementation, outlining its comprehensive strategy for high-quality sports development over the period.
The plan establishes five key targets, aiming for a per capita sports venue area of approximately 4 square meters, a regular exercise participation rate of around 40%, and a national physical fitness excellence rate of 31.1% by 2030.
It also sets goals for China to be among the leaders in world championship victories and for the total scale of the sports industry to exceed 7 trillion yuan.
The plan details specific deployments across various sectors related to building a leading sports nation, impacting Hong Kong-listed companies in the sports goods supply chain, including ANTA SPORTS (01920), LI NING (02331), and Xtep.
Market Overview
Major U.S. stock indices closed lower overnight. The Dow Jones Industrial Average dipped 0.01% to 52,218.58 points, while the S&P 500 fell 0.14% to 7,498.96 points, and the Nasdaq Composite declined 0.57% to 25,690.9 points.
Most large-cap tech stocks declined, with SpaceX dropping over 6%, Intel down more than 2%, and Microsoft falling nearly 2%.
Micron Technology and Amazon both shed over 1%. In contrast, AMD gained more than 1% and NVIDIA rose over 2%.
In post-market earnings reactions, Tesla shares fell 3%, while Alphabet, the parent company of Google, dropped 4%. Texas Instruments also declined 3%.
Mining stocks generally advanced, with Vale, Alcoa, and Gold Fields rising over 4%. Southern Copper and Freeport-McMoRan gained nearly 4%.
Computer hardware stocks were strong, with Super Micro Computer surging close to 20% and Dell Technologies climbing over 9%.
Most popular Chinese ADRs declined, with the Nasdaq Golden Dragon China Index dropping 1.80%.
Hong Kong's Hang Seng Index ADRs edged higher, indicating a potential gain of 36.84 points or 0.15% for the local market.
New York Mercantile Exchange WTI crude oil for the front-month contract rose $2.14, or 2.54%, to settle at $86.48 per barrel.
COMEX gold for the front-month contract increased by $58.60, or 1.44%, to close at $4,135.0 per ounce.
Key Developments to Watch
Baidu Group (09888) announced that its application for a dual-primary listing conversion has been acknowledged by the Hong Kong Stock Exchange.
The company, citing increased trading volume of its Hong Kong-listed shares since its secondary listing and closer ties between Hong Kong and its mainland China operations, has applied for the conversion.
The effective date for the dual-primary listing on both the Hong Kong and Nasdaq exchanges is expected within this year, pending final approval from the HKEX.
Yuejiang (02432) stated that its proposed A-share issuance and listing on the Shenzhen Stock Exchange's ChiNext board has been approved by the exchange's listing review committee, which confirmed the company meets all relevant conditions.
Huaqin Technology (03296) disclosed it has spent approximately HK$144 million to acquire a total of 4.4516 million H-shares of Jinghe Integration (02249), at an average price of about HK$32.39 per share.
Following this acquisition, the group holds about 10.82% of Jinghe Integration's total issued share capital, reflecting its confidence in the company's future prospects and long-term investment value.
Separately, on July 20, Huaqin Communications (Hong Kong) Limited increased its stake in Jinghe Integration by 3.1159 million shares at HK$29.9182 per share, for a total consideration of roughly HK$93.22 million.
PegBio Biopharma (02565) announced that the first commercial prescriptions for its product Paidacare® have been issued nationwide, and the conditions for the second milestone payment have been met.
As of July 22, 2026, initial prescriptions have been filled at several medical institutions, including Peking University People's Hospital and Xiangya Hospital of Central South University.
This marks the official entry of the drug into clinical application and patient use, representing a significant milestone from R&D and regulatory approval to commercialization for the group's first self-developed innovative drug.
MicroPort MedBot (02252) issued a positive profit alert, expecting to report a net profit between RMB 28 million and RMB 40 million for the first half of the year, a turnaround from a net loss of RMB 115 million in the same period last year, marking its first half-year profit.
Sands China (01928) reported that its total net revenue for the second quarter decreased 0.8% year-over-year to $1.78 billion under U.S. GAAP.
The company's net income for Q2 2026 fell 50.0% to $107 million, compared to $214 million in Q2 2025.
Company Spotlight
Newborn Town (09911) released unaudited operational data for the first half of 2026, indicating its innovative business segment is expected to generate revenue between $65 million and $70 million, representing year-on-year growth of approximately 35.4% to 45.8%.
The company attributed this strong growth primarily to the rapid expansion of its short-form video drama business, driven by AI technology.
During the reporting period, the company expanded its short drama operations into multiple global markets, including Europe and the U.S. Its platform, Playlet, made positive strides in high-value markets like the U.S., Japan, and South Korea, significantly increasing its user base.
In the first half, Playlet integrated with Seedance 2.0 as one of its initial partner platforms.
According to TikTok's Q1 revenue sharing report for short dramas, a hit series from the company ranked second in single-series revenue share on the platform for its first month.
With AI significantly enhancing production efficiency for short dramas, the company is positioned to leverage its localized operations and marketing capabilities to gain a competitive edge and further enrich its social entertainment content ecosystem.
Comments